市場調查報告書
商品編碼
964899

閉塞設備市場-成長,趨勢,及預測(2020年∼2025年)

Occlusion Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

閉塞設備市場成長的主要原因中,包含微創手術的採用增加,老年人口的增加,癌症等慢性疾病的盛行率增加。

本報告提供閉塞設備市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品·各終端用戶·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場推動因素
    • 微創手術的採用增加
    • 老年人口的增加和慢性病患負擔的增加
    • 技術的進步
  • 市場阻礙因素
    • 產品的高成本
    • 熟練的專業要求
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 閉塞消除設備
    • 栓塞設備
    • 支援設備
  • 各用途
    • 末稍血管疾病
    • 神經學
    • 腫瘤學
    • 泌尿科
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • BTG International Ltd
    • Edwards Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Merit Medical Systems
    • Penumbra, Inc.
    • Stryker Corporation
    • Terumo Corporation

第7章 市場機會及趨勢

目錄
Product Code: 66840

The major factors for the growth of the occlusion devices market include the rising adoption of minimally invasive surgeries, increasing geriatric population, and rising prevalence of chronic diseases such as cancer along with technological advancements.

The rising adoption of minimally invasive surgeries is expected to drive the overall growth of the market. Minimally invasive surgeries (MIS) cause less post-operative pain. The occlusion devices are used with minimal cuts or stitches involved, the hospital stay is relatively shorter and this technology is proving its efficiency in treatment while performing complex surgeries. Furthermore, there is a rising geriatric population leading to the high prevalence of chronic diseases such as cancer, and cardiovascular diseases. According to the WHO, by 2050, the world's population aged 60 years and older is expected to reach a total of 2 billion. Thus, rising geriatric population and an increase in the adoption of minimally invasive surgeries the market is expected to boost the growth of the occlusion devices market.

Key Market Trends

Neurology Segment by Application is Expected to Witness a Lucrative Growth

Artery occlusion and bypass is a two-part procedure combining open microsurgery and endovascular coiling. The purpose of this procedure is to coil the entire diseased portion of the blood vessel and then bypass the blood flow to the specific location in the brain. The difference between this procedure and endovascular coiling is that this procedure closes down (occludes) the whole vessel rather than just putting coils in the aneurysm sac.

The rising prevalence of brain aneurysm and the launch of new technologically advanced products are expected to drive the overall growth of the market. According to 2020 estimates of the Brain Aneurysm Foundation, 6.5 million people in the United States have an unruptured brain aneurysm. Furthermore, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

Women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population is increasing. As per a 2017 United Nations, the global population aged 60 years or above is expected to increase from 12.7% in 2017 to 21.3% by 2050. This is expected to increase the incidence of aneurysm. Hence, increasing incidence is expected to help the market growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest occlusion devices market owing to the rising adoption of minimally invasive surgeries and the presence of better healthcare infrastructure. Furthermore, rising approval of new occlusion devices is expected to boost the overall growth of the market.

Recently, one of the market player Abbott Laboratories received approval from FDA for the Amplatzer Piccolo Occluder, which is the world's first medical device that can be implanted in babies using a minimally invasive procedure to treat patent ductus arteriosus. The advantages of minimally invasive surgeries, such as less invasiveness, the quick recovery time of patients, and the low cost of treatment, have augmented the growth of the market in the region. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Merit Medical Systems, Penumbra, Inc., Stryker Corporation, and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Minimally Invasive Surgeries
    • 4.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Products
    • 4.3.2 Requirement of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Occlusion Removal Devices
      • 5.1.1.1 Coil Retrievers
      • 5.1.1.2 Stent Retrievers
      • 5.1.1.3 Others
    • 5.1.2 Embolization Devices
    • 5.1.3 Support Devices
  • 5.2 By Application
    • 5.2.1 Peripheral Vascular Disease
    • 5.2.2 Neurology
    • 5.2.3 Oncology
    • 5.2.4 Urology
    • 5.2.5 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 BTG International Ltd
    • 6.1.4 Edwards Lifesciences Corporation
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Medtronic plc
    • 6.1.7 Merit Medical Systems
    • 6.1.8 Penumbra, Inc.
    • 6.1.9 Stryker Corporation
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS